Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries
B. Schweikert, D. Pittrow, D. Vizza, J. Pepke-Zaba, M. Hoeper, A. Gabriel, J. Berg, M. Sikirica (Munich, Dresden, Hanover, Wuppertal, Berlin, Germany; Rome, Italy; Cambridge, United Kingdom; Stockholm, Sweden)
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Session: Pulmonary circulation: acute and chronic pulmonary embolism
Session type: Thematic Poster Session
Number: 3893
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Schweikert, D. Pittrow, D. Vizza, J. Pepke-Zaba, M. Hoeper, A. Gabriel, J. Berg, M. Sikirica (Munich, Dresden, Hanover, Wuppertal, Berlin, Germany; Rome, Italy; Cambridge, United Kingdom; Stockholm, Sweden). Demographics, clinical characteristics, health resource utilization and cost of patients with CTEPH: Retrospective results from six European countries. Eur Respir J 2012; 40: Suppl. 56, 3893
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018
Treatment patterns of COPD patients in France: A retrospective analysis of an administrative primary care healthcare database Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care Year: 2017
Evaluation of the demographics, diagnosis and monitoring, management, device usage and adherence among COPD patients: A survey of doctors in Nepal Source: International Congress 2018 – COPD around the world Year: 2018
Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021
Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021
Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study Source: Eur Respir J, 54 (4) 1900444; 10.1183/13993003.00444-2019 Year: 2019
Identifying predictors of healthcare utilization and costs in COPD patients over 18 months: first longitudinal results of the COSYCONET cohort Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018
A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data Source: Annual Congress 2008 - Management of COPD Year: 2008
The cost burden of COPD in France: A retrospective analysis of an administrative primary care database Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
The primary care routine data registry BeoNet: First pilot phase results for COPD research Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Asthma management and utilization of healthcare services in children: the results of a population-based survey Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001
Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma? Source: Eur Respir J, 50 (3) 1700644; 10.1183/13993003.00644-2017 Year: 2017
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Socio-demographic and clinical characteristics of patients with tuberculosis and diabetes in European countries. A TB-net study Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
The economic burden of COPD in a Swedish cohort: The ARCTIC study Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016